Harmony Biosciences Holdings, Inc.
NASDAQ Global Market•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Dr. Jeffrey M. Dayno M.D.
- Full Time Employees
- 246
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 630 West Germantown Pike Plymouth Meeting PA United States of America 19462
- IPO Date
- Aug 19, 2020
- CIK
- 0001802665
- Website
- harmonybiosciences.com
- Similar Companies
- Business
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Company News
Harmony Biosciences Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HRMY
Harmony Biosciences Holdings, Inc. (HRMY) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
ATTENTION Harmony Biosciences Holdings, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
Did Harmony Biosciences Holdings, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - HRMY
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY
HRMY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Harmony Biosciences Holdings, Inc. investment
HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money
Harmony Biosciences Holdings, Inc. (HRMY) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?
HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024
Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
An Investigation Has Commenced on Behalf of Harmony Biosciences Holdings, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your HRMY Losses.
Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know
HRMY vs. REGN: Which Stock Should Value Investors Buy Now?
Shareholder Rights Advocates at Levi & Korsinsky Investigate Harmony Biosciences Holdings, Inc. (HRMY) Regarding Possible Securities Fraud Violations
Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
HRMY or REGN: Which Is the Better Value Stock Right Now?
Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?